Abstract
Cu(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) is often utilized in medicinal chemistry to make the triazole moiety as it acts as a non-classical bioisostere of the peptide bond. This useful technique can also be applied in the fragment-based assembly of molecular libraries for high-throughput screening. This minireview outlines the application of click-chemistry in the synthesis of enzyme inhibitors with the triazole moiety.
Keywords: Cycloaddition, drug discovery, enzymes, high-throughput screening, organic synthesis.
Current Medicinal Chemistry
Title:Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors
Volume: 21 Issue: 13
Author(s): P. Fabbrizzi, G. Menchi, A. Guarna and A. Trabocchi
Affiliation:
Keywords: Cycloaddition, drug discovery, enzymes, high-throughput screening, organic synthesis.
Abstract: Cu(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) is often utilized in medicinal chemistry to make the triazole moiety as it acts as a non-classical bioisostere of the peptide bond. This useful technique can also be applied in the fragment-based assembly of molecular libraries for high-throughput screening. This minireview outlines the application of click-chemistry in the synthesis of enzyme inhibitors with the triazole moiety.
Export Options
About this article
Cite this article as:
Fabbrizzi P., Menchi G., Guarna A. and Trabocchi A., Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors , Current Medicinal Chemistry 2014; 21 (13) . https://dx.doi.org/10.2174/0929867321666131218093611
DOI https://dx.doi.org/10.2174/0929867321666131218093611 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements